Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2455261000168111 | Agenerase (amprenavir 150 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2455271000168117 | Agenerase 150 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Agenerase 150 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule | Is a | Agenerase | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule | Is a | amprenavir 150 mg capsule | true | Inferred relationship | Some | ||
| Agenerase 150 mg capsule | has manufactured dose form | soft capsule | false | Inferred relationship | Some | ||
| Agenerase 150 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 38540753 | |
| Agenerase 150 mg capsule | has intended active ingredient | amprenavir | true | Inferred relationship | Some | 38540752 | |
| Agenerase 150 mg capsule | has Australian BoSS | amprenavir | true | Inferred relationship | Some | 38540752 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Agenerase 150 mg capsule, 240 | has TPUU | True | Agenerase 150 mg capsule | Inferred relationship | Some | 1 |
| Agenerase 150 mg capsule, 240, bottle | has TPUU | True | Agenerase 150 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR